# Newpath Management: portfolio, investments and team > Newpath Management is a private equity based in United States. 2 investments on record, 1 in the last 12 months, latest May 2026. Source: https://millionrounds.com/fund/newpath-partners (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Newpath Management Last cheque observed May 2026; 2 cheques on record. Email Private equity Deploying now New fund, May 2026 Seed Series A Series B Life Sciences Healthcare Follow Newpath Management and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fnewpath-partners) Deploying now **100%** of best year **1** **cheques in 12 months**, 2 on record Since the last cheque **177** days **00** hrs **00** min **00** sec Median round **$98M** Rounds led **1 of 2** Pitch Newpath Management ## Newpath Management highlights - 01 1 cheques in the last 12 months - 02 Mostly Series B and Series C: 100% of its rounds - 03 Led 1 rounds ## What they do > Newpath Partners is a multi-stage life sciences and healthcare venture capital firm based in Boston, MA. From their own website - **Type:** Private equity (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B - **Sectors:** Life Sciences Healthcare - **Based in:** Boston, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **2 appearances** - **2026** 1 round - **May** **[CREATE Medicines](https://millionrounds.com/company/create-medicines)** Series B · US · Hatteras Venture Partners **$122M** *Led* - **2023** 1 round - **May** **[Myeloid Therapeutics, Inc.](https://millionrounds.com/company/myeloid-therapeutics-inc)** Series C · US · Hatteras Venture Partners **$73M** With 5 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **1 named** TJ **Thomas Joseph Cahill** Co-Founder and Managing Partner i Form ADV We also hold **1** person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$724M** gross assets of its funds Oct 2026 **Exempt** reporting adviser venture or small private funds - **Legal name:** Newpath Management, L.P. - **SEC number:** CRD 300064 New fund on file **Raised** a new fund in May 2026 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Seed Series A Series B Median round joined **$98M** the round, not its cheque Led 1 of 2 rounds **50%** - **Sole investor:** Never alone - **Last cheque:** May 2026 Rounds by stage said on their site - Series B said *1* - Series C *1* - Seed said *-* - Series A said *-* Cheques by month Led Joined Dec 2023 Nov 2026 Often in the room with - [8VC](https://millionrounds.com/fund/8vc) 2 - [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) 2 - [Hatteras Venture Partners](https://millionrounds.com/fund/hatteras-venture-partners) 2 **Pitching Newpath Management?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Newpath Management. A count of rooms they were both in, not a relationship either has claimed. [**8VC** VC firm **2** rounds together](https://millionrounds.com/fund/8vc)[**ARCH Venture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/arch-venture-partners)[**Hatteras Venture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/hatteras-venture-partners) ## Recently backed The latest companies Newpath Management put money into. [**CREATE Medicines** $122M · May 2026](https://millionrounds.com/company/create-medicines) ## Quick answers about Newpath Management ### What does Newpath Management invest in? Newpath Management invests most often at Series B and Series C (100% of the rounds on record), in sectors such as Life Sciences and Healthcare. ### How active is Newpath Management? 2 investments on record, 1 of them in the last 12 months, and it led 1. The most recent was in May 2026. ### What has Newpath Management invested in recently? Its most recent investments on record: CREATE Medicines (Series B, May 2026) and Myeloid Therapeutics, Inc. (Series C, May 2023). ### How big are Newpath Management's cheques? The median round it joins is $98M. ### Is Newpath Management investing now? Yes: it is actively investing, with 1 investments in the last 12 months. ### Who does Newpath Management invest alongside? Most often 8VC (2 rounds together), ARCH Venture Partners (2 rounds together) and Hatteras Venture Partners (2 rounds together). ### What kind of investor is Newpath Management? Newpath Management is a private equity firm based in Boston, United States. ### How much does Newpath Management manage? About $724M, as gross assets of its private funds (Oct 2026). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=newpath-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=newpath-partners)